Tøndel disputerer for ph.d.-graden i helsevitenskap og vil offentlig forsvare avhandlingen:
"The risk of venous thromboembolism after ischemic stroke."
Avhandlingen er tilgjengelig her! / The doctoral thesis is available here!
Disputasen strømmes og et opptak vil være tilgjengelig i et døgn.
The defense will be streamed, and a recording of the disputation will be available for 24 hours.
Prøveforelesning over oppgitt emne starter kl. 10.30 / The trial lecture starts at 10.30
Tittel/Title: "The management of thrombosis prophylaxis in ischemic and hemorrhagic stroke."
Prøveforelesningen strømmes her / The trial lecture will be streamed here.
Disputasen starter kl. 12.30 / The defense starts at 12.30
Disputasen strømmes her / The defense will be streamed here
Populærvitenskapelig sammendrag av avhandlingen/ Summary of the thesis:
Venous thromboembolism (VTE) after ischemic stroke complicates recovery and is linked to poor outcomes. Anticoagulant drugs reduce VTE-risk but increase the chance of major, potentially fatal bleeding, and should be reserved for high-risk patients. However, which patients face the highest risk remains unclear, making targeted prevention challenging.
In this thesis, we systematically reviewed previous studies and identified 16 factors that may help identify high-risk patients, though further evaluation is needed. Using large population-based studies from Norway, we found that VTE-risk was similar in men and women, that obesity did not further increase the risk beyond its individual effect, and that transient, provoking risk factors likely play a key role.
Finally, despite major advances in stroke care, the risk of VTE after stroke has not declined over time, emphasizing the need for more effective strategies to reduce VTE burden in stroke patients.
Hovedveileder/Main supervisor:
Professor Sigrid Kufaas Brækkan, Institutt for klinisk medisin, Det helsevitenskapelige fakultet, UiT Norges arktiske universitet.
Bedømmelseskomité/Defensecomitee:
Professor Karina Meijer, University Medical Centre Groningen, Netherlands – 1. opponent.
Professor Marcus Lind, Umeå Universitet, Sweden – 2. opponent.
Professor Lars Småbrekke, Institutt for farmasi, Det helsevitenskapelige fakultet, UiT Norges arktiske universitet – leder av komité.
Disputasleder/ Leader of defense:
Førsteamanuensis Torgil Vangberg, Institutt for klinisk medisin, Det helsevitenskapelige fakultet, UiT Norges arktiske universitet.
When: 22.01.26 at 10.30–16.00
Where:
Aud Cerebrum, plan 8, MH Vest
Location / Campus: Digital, Tromsø
Target group: Employees, Students, Guests, Invited, Unit
Contact: Tom Edvard Roll
E-mail: tom.e.roll@uit.no